Last update - 16.10pm 16/03/2026 (20 minute delay)
?
| Day |
| Open |
3.7¢ |
|
Day High |
3.9¢ |
|
Day Low |
3.6¢ |
| Daily Volume |
2137440 |
| Bids |
|
Sellers |
| Number |
Price |
Volume |
|
Number |
Price |
Volume |
| 0 |
3.8¢ |
135134 |
|
0 |
3.9¢ |
998940 |
Directors & Senior Management
| Mr. Andrew B. Udell |
Chief Commercial Officer |
| Prof. Brian R. Walker |
Member of Scientific Advisory Board |
| Dr. Christina Kurre Olsen |
Member of Depression & Cognition Clinical Advisory Board |
| Dr. Christopher Chen |
Member of Depression & Cognition Clinical Advisory Board |
| Prof. Colin Louis Masters |
Member of Xanamem Clinical Advisory Board |
| Prof. Craig W. Ritchie |
Chairman of Xanamem Clinical Advisory Board |
| Dr. Dana C. Hilt |
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board |
| Dr. Fujun Li |
Head of Manufacturing |
| Dr. Geoffrey Edward Duncan Brooke |
Independent Non-Executive Chairman |
| Dr. George Morstyn |
Independent Non-Executive Director |
| Dr. John Harrison |
Member of Depression & Cognition Clinical Advisory Board |
| Prof. Jonathan Seckl |
Member of Scientific Advisory Board |
| Mr. Malcolm John McComas |
Independent Non-Executive Director |
| Mr. Michael Roberts |
Head of Investor Relations & Corporate Communications |
| Dr. Nicki Vasquez |
Independent Non-Executive Director |
| Prof. Paul Rolan |
Head of Clinical Pharmacology & Lead Physician and Depression |
| Mr. Peter Gordon Webse |
Company Secretary |
| Prof. Scott Webster |
Member of Scientific Advisory Board |
| Dr. Steven G. Gourlay |
MD, CEO & Director |
| Mr. William Edward Souter |
Chief Financial Officer |
Data source: ADVFN
